BioNano Genomics Raises $5M | GenomeWeb

NEW YORK (GenomeWeb) – Genome mapping company BioNano Genomics said in a regulatory filing that it raised $5 million toward a targeted $6.1 million financing round.

In a document filed with the US Securities and Exchange Commission last week, BioNano said that the type of securities offered included debt; option, warrant, or other rights to acquire another security; and security to be acquired upon the exercise of an option, warrant, or other right to acquire security.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: genetic target for urothelial bladder cancer treatment, and more.

At the Conversation, the University of Oxford's Michael Macklay writes that learning genetic risk of disease is a personal decision.

Two dozen scientific organizations have endorsed the March for Science, according to ScienceInsider.

Researchers in Japan describe a chimpanzee with a chromosomal abnormality similar to human Down syndrome, Mashable reports.